Skip to main content
. 2019 Apr 30;176(2):377–386. doi: 10.1007/s10549-019-05226-8

Fig. 3.

Fig. 3

Univariable hazard ratios (95% CI) for the prognostic value of EPclin for DR according to treatment group and follow-up period